Secondary tumor analysis revealed higher CD8+/CD4+ T cell infiltration and significant CD44+CD62L− effector memory T cell expansion (Fig. 2h, i), demonstrating systemic immune activation capable of suppressing distant tumors and establishing durable immune memory. The gene discussed is CD44; the disease is neoplasm.